Persistence of occult metastatic cells in bone marrow after adjuvant systemic therapy predicts relapse in localized breast cancer.

被引：0
|
作者：
Bermejo, B
Lluch, A
Benet, I
Sastre, JM
Ferrer, JV
Garcia, T
Chumbes, L
Martinez, P
Garcia-Conde, J
机构：
[1] Hosp Clin, Dept Hematol & Oncol, Valencia, Spain
[2] Univ Valencia, Dept Stat, E-46003 Valencia, Spain
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2004年 / 22卷 / 14期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
657
引用
收藏
页码：41S / 41S
页数：1
相关论文
共 50 条
  • [31] Persistence of isolated tumor cells (ITC) in bone marrow (BM) of breast cancer patients predicts increased risk for relapse - results of pooled European data.
    Janni, W
    Wiedswang, G
    Borgen, E
    Braun, S
    Rack, B
    Schindlbeck, C
    Sommer, H
    Pantel, K
    Heinrigs, M
    Gerber, B
    Nesland, JM
    Scholz, C
    Friese, K
    Jeschke, U
    Naume, B
    BREAST CANCER RESEARCH AND TREATMENT, 2005, 94 : S44 - S44
  • [32] TREATMENT OF RELAPSE OF BREAST-CANCER AFTER ADJUVANT SYSTEMIC THERAPY - REVIEW AND GUIDELINES FOR FUTURE-RESEARCH
    RUBENS, RD
    BAJETTA, E
    BONNETERRE, J
    KLIJN, JGM
    LONNING, PE
    PARIDAENS, R
    EUROPEAN JOURNAL OF CANCER, 1994, 30A (01) : 106 - 111
  • [33] erbB2 overexpression on occult metastatic cells in bone marrow predicts poor clinical outcome of stage I-III breast cancer patients
    Braun, S
    Schlimok, G
    Heumos, I
    Schaller, G
    Riethdorf, L
    Riethmüller, C
    Pantel, K
    CANCER RESEARCH, 2001, 61 (05) : 1890 - 1895
  • [34] Biomarker evolution after neoadjuvant systemic therapy in breast cancer.
    Castillo, Dan Ran
    Pairawan, Seyed Saeed
    Denham, Laura
    Lum, Sharon S.
    Nagaraj, Gayathri
    JOURNAL OF CLINICAL ONCOLOGY, 2022, 40 (16)
  • [35] Microscopic Disease in Blood and Bone Marrow Predicts Survival in Early Stage Breast Cancer.
    Lucci, A.
    Krishnamurthy, S.
    Lodhi, A.
    Bhattacharyya, A.
    Hall, C.
    Anderson, A.
    Bedrosian, I.
    Singh, B.
    Kuerer, H.
    CANCER RESEARCH, 2011, 71
  • [36] Persistance of isolated tumor cells (ITC) in bone marrow (BM) of breast cancer patients predicts increased risk for relapse
    Janni, Wolfgang
    Rack, Brigitte
    Schindlbeck, Christian
    Strobl, Barbara
    Rjosk, Dorothea
    Sommer, Harald
    Gerber, Bernd
    Pantel, Klaus
    Braun, Stephan
    Friese, Klaus
    ANNALS OF ONCOLOGY, 2004, 15 : 59 - 59
  • [37] The pattern of chemokine receptors expressed by tumor cells predicts the site of metastatic relapse in patients with axillary node positive breast cancer.
    Andre, F
    Cabioglu, N
    Assi, H
    Sabourin, JC
    Delaloge, S
    Sahin, A
    Soria, JC
    Cristofanilli, M
    JOURNAL OF CLINICAL ONCOLOGY, 2005, 23 (16) : 837S - 837S
  • [38] Detection of cytokeratin-positive cells in the bone marrow of breast cancer patients undergoing adjuvant therapy
    Sven Becker
    Graziella Becker-Pergola
    Diethelm Wallwiener
    Erich-Franz Solomayer
    Tanja Fehm
    Breast Cancer Research and Treatment, 2006, 97 : 91 - 96
  • [39] Detection of cytokeratin-positive cells in the bone marrow of breast cancer patients undergoing adjuvant therapy
    Becker, Sven
    Becker-Pergola, Graziella
    Wallwiener, Diethelm
    Solomayer, Erich-Franz
    Fehm, Tanja
    BREAST CANCER RESEARCH AND TREATMENT, 2006, 97 (01) : 91 - 96
  • [40] Proliferation of prostate cancer cells in the bone marrow predicts recurrence in patients with localized prostate cancer
    Bianco, FJ
    Wood, DP
    de Oliveira, JG
    Nemeth, JA
    Beaman, AA
    Cher, ML
    PROSTATE, 2001, 49 (04): : 235 - 242
12345